New monthly shot shows promise for controlling acromegaly Long-Term
Disease control
Completed
This study tested the long-term safety of a monthly injection called CAM2029 in 135 adults with acromegaly, a condition where the body makes too much growth hormone. Participants received the shot once a month for 12 months. The main goal was to check for side effects, and the st…
Phase: PHASE3 • Sponsor: Camurus AB • Aim: Disease control
Last updated May 15, 2026 11:57 UTC